Domov › Alopecia areata › Texas
Klinické štúdie Alopecia areata v štáte Texas
7 štúdií pre Alopecia areata hľadá účastníkov v zariadeniach v štáte Texas.
Mestá v štáte Texas
Oficiálny text štúdie (anglicky)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
Prebieha náborFáza 2
Vek 18 až 50 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Center for Clinical Studies - Clear Lake, Webster
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- Dfw Clinical Trials /ID# 284604, Carrollton
- a 5 ďalších
Prebieha náborFáza 3
Vek 12 až 63 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- 3A Research, El Paso
- Texas Dermatology and Laser Specialists, San Antonio
Prebieha náborFáza 3
Vek 6 až 14 · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- a 1 ďalších
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 28. 1. 2026 · NCT07133308Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.